Jazz Pharmaceuticals (JAZZ) Long-Term Debt Issuances (2010 - 2020)
Jazz Pharmaceuticals' quarterly Long-Term Debt Issuances came in at $981.4 million in Q4 2020, up 1078540.66% quarter-over-quarter from -$91000.0 in Q4 2017.
Jazz Pharmaceuticals has reported Long-Term Debt Issuances for 7 years, with the latest figure at $981.4 million in Q4 2020.
- For the quarter ending Q4 2020, Long-Term Debt Issuances changed N/A year-over-year to $981.4 million; the trailing twelve-month figure through Sep 2022 stood at $981.4 million (changed 0.0% YoY), and the FY2024 full-year result was $980.8 million, changed N/A from the prior year.
- Long-Term Debt Issuances for Q4 2020 stood at $981.4 million, up from -$91000.0 in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $994.8 million in Q3 2016, with the low at -$130000.0 in Q4 2016.
- Average Long-Term Debt Issuances over 3 years is $494.0 million, with a median of $490.6 million recorded in 2017.
- Year-over-year, Long-Term Debt Issuances soared 48791.97% in 2016 and soared 30.0% in 2017.
- Tracing JAZZ's Long-Term Debt Issuances over 3 years: stood at -$130000.0 in 2016, then gained by 30.0% to -$91000.0 in 2017, then soared by 1078540.66% to $981.4 million in 2020.
- The last three Long-Term Debt Issuances figures came in at $981.4 million (Q4 2020), -$91000.0 (Q4 2017), and -$130000.0 (Q4 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.73 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 981.38 Mn |
| Dec 31, 2020 | 981.38 Mn |
| Dec 31, 2017 | -91,000.00 |
| Dec 31, 2017 | -91,000.00 |
| Dec 31, 2016 | -130,000.00 |
| Dec 31, 2016 | -130,000.00 |
| Sep 30, 2016 | 994.78 Mn |
| Sep 30, 2016 | 994.78 Mn |
| Dec 31, 2015 | -318,000.00 |
| Dec 31, 2015 | -318,000.00 |
| Sep 30, 2015 | -2.04 Mn |
| Sep 30, 2015 | -2.04 Mn |
| Jun 30, 2015 | 901.00 Mn |
| Jun 30, 2015 | 901.00 Mn |
| Dec 31, 2014 | -981,000.00 |
| Dec 31, 2014 | -981,000.00 |
| Sep 30, 2014 | 559.01 Mn |
| Sep 30, 2014 | 559.01 Mn |
| Mar 31, 2014 | 636.36 Mn |
| Mar 31, 2014 | 636.36 Mn |
| Sep 30, 2013 | 553.43 Mn |
| Sep 30, 2013 | 553.43 Mn |
| Jun 30, 2013 | 553.43 Mn |
| Jun 30, 2013 | 553.43 Mn |
| Dec 31, 2010 | -261,000.00 |
| Dec 31, 2010 | -261,000.00 |